939757-89-8 Usage
General Description
4-Phenyl-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) ester, also known as TMB-8, is a chemical compound used in biological and medical research. It is commonly used as a membrane-permeable inhibitor of the intracellular calcium release channels in cells, impacting the release of intracellular calcium stores and calcium influx. TMB-8 is also used to study the role of calcium in various physiological and pathological processes, such as cell signaling, muscle contraction, and neurotransmitter release. Additionally, it has been investigated for its potential therapeutic applications in treating conditions such as cardiovascular diseases and neurological disorders. TMB-8 is a versatile tool for investigating the role of calcium channels in cellular function and is a valuable compound in the field of pharmacology and biomedical research.
Check Digit Verification of cas no
The CAS Registry Mumber 939757-89-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,9,7,5 and 7 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 939757-89:
(8*9)+(7*3)+(6*9)+(5*7)+(4*5)+(3*7)+(2*8)+(1*9)=248
248 % 10 = 8
So 939757-89-8 is a valid CAS Registry Number.
939757-89-8Relevant articles and documents
HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6
-
, (2021/09/04)
The present disclosure relates to compounds capable of modulating the activity of NR2F6. The compounds of the disclosure may be used in methods for the prevention and/or the treatment of diseases and disorders associated with modulating NR2F6 activity.
Process for the preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carbocyclic acids
-
Page/Page column 22; 23, (2008/06/13)
The present invention relates to a process for the preparation of cis substituted cyclic β-aryl or heteroaryl carboxylic acid derivatives in high diastereo- and enantioselectivity by enantioselective hydrogenation in accordance with the following scheme w